Join the Wegovy group to help and get support from people like you.
Wegovy News (Page 5)
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic
WEDNESDAY, Jan. 22, 2025 – Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities, federal health officials announced in...
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
TUESDAY, Jan. 21, 2025 – Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even...
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
TUESDAY, Jan. 21, 2025 – Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even...
The New Definition of Obesity
The way obesity is diagnosed needs to become more sophisticated, an international commission has concluded. Using body-mass index (BMI) to tell who is overweight or obese is not reliable, and can...
Perioperative GLP-1 RA Use Reduces Risk for Complications in Patients With Diabetes
MONDAY, Jan. 13, 2025 – For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription is associated with...
Semaglutide Doubles Risk for Nonarteritic Anterior Ischemic Optic Neuropathy
TUESDAY, Jan. 14, 2025 – Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes, according to a...
Can Elderberry Juice Help You Lose Weight?
FRIDAY, Jan. 10, 2025 – Ozempic? Wegovy? Zepbound? How about elderberry juice? Elderberry juice might help people lose weight and improve their blood sugar control, a new small-scale study says....
Some GLP-1s Achieve More Weight Loss Than Others: Study
WEDNESDAY, Jan. 8, 2025 – Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been approved for that purpose. A new evidence review published ...
GLP-1 RAs Efficacious for Weight Loss in Overweight, Obesity Without Diabetes
TUESDAY, Jan. 7, 2025 – For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published...
How do GLP-1s Boost Weight Loss, Heart Health?
THURSDAY, Jan. 2, 2024 – Weight loss tops many folks’ list of New Years resolutions, and lots of people are turning to cutting-edge weight-loss drugs like Ozempic to help them drop excess pounds. T...
Weight-Loss Drugs, Wily Viruses, Abortion Pill Under Attack: The Top Health Stories of 2024
MONDAY, Dec. 30, 2024 – It was a year in health news that will be hard to forget. As blockbuster weight-loss drugs known as GLP-1s made a sizable dent in the obesity epidemic, study after study...
U.S. Adult Obesity Rate Fell in 2023, as Use of GLP-1 Meds Rose
FRIDAY, Dec. 13, 2024 – The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss meds, a new study finds. Data on almost 17 million...
GLP-1 RAs Reduce Risk for Clinically Important Kidney, CVD Outcomes
FRIDAY, Dec. 6, 2024 – Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) reduce the risk for clinically important kidney and cardiovascular disease outcomes in individuals with type 2 diabetes,...
Weight Loss Brings Americans Big Health Care Savings
THURSDAY, Dec. 5, 2024 – The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs' cost should be covered by Medicare, Medicaid and private...
Zepbound Bests Wegovy for Weight Loss in New Trial
WEDNESDAY, Dec. 4, 2024 – Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. "Given the increased...
Further information
Related condition support groups
Weight Loss (Obesity / Overweight), Cardiovascular Risk Reduction